Cataract Surgery in Eyes With Epiretinal Membrane

Retinal Thickness Change Following Cataract Surgery in Eyes With Epiretinal Membrane

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03404323

Enrollment

Registered

2018-01-19

Start date

2015-07-01

Completion date

2017-05-01

Last updated

2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Epiretinal Membrane, Irvine-Gass Syndrome, Pseudophakic Cystoid Macular Edema

Keywords

central retinal thickness, epiretinal membrane, cataract surgery, pseudophakic cystoid macular edema

Brief summary

The purpose of the study is to evaluate retinal thickness change and the occurrence of central structural retinal changes after uneventful small-incision cataract surgery in eyes with asymptomatic early stages of epiretinal membrane.

Detailed description

Optical coherence tomography (OCT) is nowadays used in daily clinical practice and has become a helpful tool for detection of macular changes also in presence of opacification of the lens before cataract surgery. Using recent high-resolution OCT technology, early stages of epiretinal membranes can easily be detected and analysed. Since cataract surgery is one of the most frequently performed operations worldwide, this study was aimed to investigate the influence of uncomplicated cataract surgery on central retinal thickness and the incidence of structural and morphological macular changes after surgery in eyes with asymptomatic epiretinal membrane.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* visually compromising cataract and asymptomatic early stages of epiretinal membrane with no structural changes such as cysts or photoreceptor distribution in optical coherence tomography.

Exclusion criteria

* visual impairment or metamorphopsia due to epiretinal membrane * history of branch retinal vein occlusion * central retinal vein occlusion * wet or dry macular degeneration * diabetic retinopathy * uveitis or other inflammatory eye disease.

Design outcomes

Primary

Measure	Time frame	Description
central macular thickness	Change from Baseline central macular thickness at 3 months	Central 1-millimeter and 3-milimeter retinal thickness

Outcome results